Bioresorbable implants are prosthetic in nature and are made from polymer having a property to gradually decompose with the passage of time. It is used to support, enhance, and regularize the physiological function in the human body. Different types of material used in bioresorbable implants are Poly lactic-co-glycolic acid (PLGA), Poly L-lactide (PLLA), and others. The PLGA bioresorbable implant are actively used in periodontal therapy.
Market Dynamics
Increasing prevalence of trauma injuries, osteoporosis, and cardiovascular diseases is a major factor driving bioresorbable implants market growth. According to World Health Organization (WHO) factsheet in 2018, annually there are around 37.3 million falls, which require medical attention whereas an estimated 646,000 individuals die annually from falls globally. Moreover, advantages of bioresorbable polymer implants over metallic implants are expected to boost the market growth. Bioresorbable implants degrade after completion of its function, which is considered as the major advantage of bioresorbable implants over the permanently installed devices. Bioresorbable implants also bypasses the need of second surgery for the removal of the implant, making the process cost effective as compared to the non-biodegradable implants. However, bare metal implants or inert metallic implants lead to serious and life threating conditions such as neoatherosclerosis, late stent thrombosis, and local inflammation due to the presence of a foreign body.
Key features of the study:
- This report provides in-depth analysis of the bioresorbable implants market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global bioresorbable implants market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Bioretec Ltd., CONMED Corporation, Depuy Synthes, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew Plc., and Boston Scientific Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
- The global bioresorbable implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bioresorbable implants market
Detailed Segmentation:
- Global Bioresorbable Implants Market, By Material Type:
- Metallic
- Polymer
- PLGA- Poly lactic-co-glycolic acid
- PLLA- Poly L-lactide
- PGA- Polyglycolic Acid
- PLA- Polylactic Acid
- Others
- Global Bioresorbable Implants Market, By Application:
- Orthopedic
- Cardiovascular
- Others
- Global Bioresorbable Implants Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Global Bioresorbable Implants Market, By Geography:
- North America
- By Material Type:
- Metallic
- Polymer
- PLGA- Poly lactic-co-glycolic acid
- PLLA- Poly L-lactide
- PGA- Polyglycolic Acid
- PLA- Polylactic Acid
- Others
- By Application:
- Orthopedic
- Cardiovascular
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Country:
- Latin America
- By Material Type:
- Metallic
- Polymer
- PLGA- Poly lactic-co-glycolic acid
- PLLA- Poly L-lactide
- PGA- Polyglycolic Acid
- PLA- Polylactic Acid
- Others
- By Application:
- Orthopedic
- Cardiovascular
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Material Type:
- Metallic
- Polymer
- PLGA- Poly lactic-co-glycolic acid
- PLLA- Poly L-lactide
- PGA- Polyglycolic Acid
- PLA- Polylactic Acid
- Others
- By Application:
- Orthopedic
- Cardiovascular
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Material Type:
- Metallic
- Polymer
- PLGA- Poly lactic-co-glycolic acid
- PLLA- Poly L-lactide
- PGA- Polyglycolic Acid
- PLA- Polylactic Acid
- Others
- By Application:
- Orthopedic
- Cardiovascular
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Material Type:
- Metallic
- Polymer
- PLGA- Poly lactic-co-glycolic acid
- PLLA- Poly L-lactide
- PGA- Polyglycolic Acid
- PLA- Polylactic Acid
- Others
- By Application:
- Orthopedic
- Cardiovascular
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Ambulatory Surgical Centers
- Specialty Clinics
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Material Type:
- Metallic
- Polymer
- PLGA- Poly lactic-co-glycolic acid
- PLLA- Poly L-lactide
- PGA- Polyglycolic Acid
- PLA- Polylactic Acid
- Others
- By Application:
- Orthopedic
- Cardiovascular
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Bioretec Ltd. *
- Company Overview
- Product Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- CONMED Corporation
- Depuy Synthes
- Stryker Corporation
- Smith & Nephew Plc.
- Zimmer Biomet Holdings Inc.
- Boston Scientific Corporation
“*” marked represents similar segmentation in other categories in the respective section.
